# Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated Epilepsy

> **NCT05422664** · — · UNKNOWN · sponsor: **Liu Yonghong** · enrollment: 500 (estimated)

## Conditions studied

- Autoimmune Encephalitis
- Epilepsy
- Seizures

## Interventions

- **DRUG:** Lacosamide

## Key facts

- **NCT ID:** NCT05422664
- **Lead sponsor:** Liu Yonghong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-07-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05422664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05422664, "Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated Epilepsy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05422664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*